Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells

Zoltán Hujber, Anna Sebestyén|Journal of Experimental & Clinical Cancer Research|2017

Cited by 23